TABLE 3.
Admission clinical data for 79 adults without TBM
| Variable | No. (%) or median (range) |
|---|---|
| Male sex | 48 (60.7) |
| Age (yr) | 37 (15-75) |
| HIV infection | 8 (10) |
| Duration of symptoms before treatment (days) | 10 (5-27) |
| Vol of CSF (ml) | 3.5 (0.5-10) |
| CSF opening pressure (cm of H2O) | 21 (8-40) |
| CSF total white cells (103/ml) | 780 (5-3050) |
| % Neutrophils | 35 (0-95) |
| % Lymphocytes | 62 (10-100) |
| CSF protein (mg/dl) | 125 (66-230) |
| CSF lactate (mmol/liter) | 3.8 (1.6-12.0) |
| CSF chloride (mmol/liter) | 114 (93-125) |
| CSF/blood glucose ratio | 0.35 (0.10-0.55) |